Treatment Patterns and Associated Health Care Costs Before and After Treatment Initiation Among Pulmonary Arterial Hypertension Patients in the United States

BACKGROUND: Despite multiple treatment options, the prognosis of pulmonary arterial hypertension (PAH) remains poor. PAH patients experience a high economic burden due to comorbidities, hospitalizations, and medication costs. Although combination therapy has been shown to reduce hospitalizations, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Burger, Charles D., Ozbay, A. Burak, Lazarus, Howard M., Riehle, Ellen, Montejano, Leslie B., Lenhart, Gregory, White, R. James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398102/
https://www.ncbi.nlm.nih.gov/pubmed/29436260
http://dx.doi.org/10.18553/jmcp.2018.17391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398102/
https://www.ncbi.nlm.nih.gov/pubmed/29436260
http://dx.doi.org/10.18553/jmcp.2018.17391

Ejemplares similares